High-end newsletter focused on small-cap biotech stocks, using what they call their CASH system to select recommended stocks (Catalysts, large Addressable market, good Science, and a potential Hype story). Wood also edits the “entry level” healthcare investment advisory Healthy Returns.
Rating: 2.8/5. From 6 votes.
Rating from 21 votes
If you’ve subscribed to Biotech Millionaire, please click the stars below to indicate your rating for this newsletter, and please share any other feedback about your experience using the comment box below.